Results 81 to 90 of about 4,214 (122)

Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study. [PDF]

Blood Adv
García-Sanz R, Owen RG, Jurczak W, Dimopoulos MA, McCarthy H, Cull G, Opat SS, Castillo JJ, Kersten MJ, Wahlin BE, Grosicki S, Prathikanti R, Tian T, Allewelt H, Cohen AC, Tam CS.   +15 more
europepmc   +1 more source

Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia. [PDF]

Blood Adv
Castillo JJ, Guijosa A, Allan JN, Siddiqi T, Advani RH, Flynn CA, Meid K, Budano N, Nguyen J, Ramirez-Gamero A, Tsakmaklis N, Hunter ZR, Patterson CJ, Treon SP, Sarosiek S.   +14 more
europepmc   +1 more source

A real-world 10-year follow-up analysis of survival and safety of CD20-targeted therapy in patients with Waldenstrom macroglobulinemia. [PDF]

Front Oncol
Zhang H, Huang X, Zhu Y, Zheng Z, Zhan R, Wang S.   +5 more
europepmc   +1 more source

Successful Treatment of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Complicated by Severe Autoimmune Neutropenia With Rituximab and Bendamustine. [PDF]

Cureus
Edahiro T, Yoshida T, Nakatani S, Ureshino H, Ichinohe T.   +4 more
europepmc   +1 more source

Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenström macroglobulinemia: a pooled analysis. [PDF]

Blood Adv
Guijosa A, Ramirez-Gamero A, Sarosiek S, Branagan AR, von Keudell G, Treon SP, Castillo JJ.   +6 more
europepmc   +1 more source

Multi-omics analysis reveals a unique epigenetic signature in <i>MYD88</i> wild-type Waldenström macroglobulinemia. [PDF]

Haematologica
Chohan K, Paludo J, Dasari S, Novak JP, Abeykoon JP, Zanwar S, Yang ZZ, Jalali S, Bhardwaj V, Krull JE, Braggio E, Manske MK, Reeder CB, Ailawadhi S, Chanan-Khan A, Kapoor P, Kyle RA, Gertz MA, Novak AJ, Mondello P, Ansell SM.   +20 more
europepmc   +1 more source

Waldenström Macroglobulinemia Diagnosed by Ultrasonography-Guided Biopsy of the Right Perinephric Tumor. [PDF]

IJU Case Rep
Morinaga S, Aoki S, Tobiume M, Nishikawa G, Higuchi F, Ikenohata Y, Honda M, Kubo H, Sawada T, Yamada Y.   +9 more
europepmc   +1 more source

Cutaneous macroglobulinosis with Waldenström macroglobulinemia and Bing-Neel syndrome: A case report. [PDF]

JAAD Case Rep
Khogeer A, Dupuy A.
europepmc   +1 more source

Long-term outcomes and treatment patterns in Waldenström macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy. [PDF]

Blood Cancer J
Chohan KL, Gensini L, Seif S, Sun X, Feng L, Becnel MR, Gaballa MM, Lee HC, Pasvolsky O, Patel KK, Ye JC, Weber DM, Orlowski RZ, Thomas SK.   +13 more
europepmc   +1 more source